Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes is one of 9,000 studies in the ScholarPulse dataset. Key details — Authors: Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn; Journal / source: New England Journal of Medicine; Year: 2018.
| Authors | Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn |
|---|---|
| Journal / source | New England Journal of Medicine |
| Year | 2018 |
| Field | Diabetes Treatment and Management |
| Times cited | 6284 |
| Type | article |
| DOI / link | https://doi.org/10.1056/nejmoa1812389 |